Professional Summary

Professional Overview

Jason O'Byrne is an accomplished Chief Financial Officer with extensive experience in the biotechnology and pharmaceutical industries. He specializes in financial strategy, operational optimization, and driving business growth through data-driven decision-making.

Experience Summary

Current Role

As the Chief Financial Officer at Vir Biotechnology, Inc., Jason is responsible for overseeing the company's financial operations, risk management, and strategic planning. He plays a pivotal role in supporting the organization's mission to develop innovative therapies for infectious diseases. Under his leadership, the finance team has implemented robust financial controls, improved cash flow management, and enhanced reporting capabilities to drive operational efficiency and support the company's rapid growth.

Career Progression

Prior to his current role, Jason served as the Chief Financial Officer at Caribou Biosciences, where he led the company's successful transition to a public company, securing significant funding to advance its gene editing technology platform. Before that, he held various finance leadership positions at Astellas Gene Therapies and Genentech, where he played a crucial role in shaping the financial strategies and operational excellence of these leading biotechnology companies.

Academic Background

Jason holds a Bachelor of Science in Mechanical Engineering from the University of Michigan and an MBA from the University of Chicago Booth School of Business. He is recognized for his academic achievements, including being named to the Dean's List during his undergraduate studies.

Areas of Expertise

• Financial planning and analysis

• Mergers, acquisitions, and integration

• Capital raising and investor relations

• Regulatory compliance and risk management

• Business process optimization

• Cross-functional team leadership

Professional Impact

Throughout his career, Jason has demonstrated a strong track record of driving financial performance and operational improvements. He has led the successful integration of acquired companies, streamlined financial processes, and implemented data-driven decision-making frameworks that have resulted in significant cost savings and enhanced profitability for the organizations he has served.

Conclusion

With his extensive experience in the biotechnology and pharmaceutical industries, Jason O'Byrne is a seasoned financial executive who consistently delivers results and contributes to the long-term success of his employers. His strategic mindset, technical expertise, and collaborative leadership style make him a valuable asset to any organization seeking to optimize its financial operations and drive sustainable growth.